Global Aflatoxicosis Treatment Market: Overview
Toxic metabolites known as mycotoxins are produced by the aspergillus flavours and aspergillus parasiticus. The toxic strains of A.parasiticus and A.flavus produce aflatoxin on the soybeans, corn, peanuts, wheat, and other cereals that are cultivated in the field or during the storage. For the growth of the molds, moisture and high temperature are the favorable conditions. The occurrences of the disease and the toxicity level in the mammals vary depending on the species, nutritional status, sex, age, duration of intake, and the strength of aflatoxin. The problems that are caused by consuming aflatoxins are nausea, abdominal pain, vomiting, convulsions, cerebral edema, pulmonary edema, blood abnormalities such as severe damage to the liver, increased the threat of bleeding of blood out, damage to the heart and kidneys. There is no complete treatment for the aflatoxicosis. Therefore the treatment for aflatoxicosis focuses on the supportive care for heart disease, liver disease, and other aflatoxicosis manifestations.
Global Aflatoxicosis Treatment Market: Segmentation
The market for aflatoxicosis treatment is globally fragmented into its treatment and regions. Based on the treatment, the global market is segregated into oxygen therapy, antihistamines, antibiotics, immunosuppressants, blood transfusion, and others. Based on the geographical regions, the market is diversified into North America, the Middle East & Africa, Eastern Europe, Western Europe, Latin America, and Asia Pacific.
Global Aflatoxicosis Treatment Market: Growth Factors
The primary factor that is rapidly developing the global aflatoxicosis treatment market is the high exposure of the staple supplies to the contamination that is observed in the overall regions coupled with the system of food storage, production, and marketing. In the developing countries, the shortage of the storage facilities for the staple supplies and the crops leads to the contamination by the fungus such as penicillium and aspergillus is the primary factor that is triggering the aflatoxicosis treatment market. The market growth can be affected negatively due to the inappropriate supply of the immunosuppressive agents and antibiotics as the antigenic determinant that causes the aflatoxicosis can vary and may develop resistance to the method of treatment after a time period.
Global Aflatoxicosis Treatment Market: Regional Analysis
The regional markets that are leading the aflatoxicosis treatment market are Latin America, Asia Pacific, and the Middle East & Africa. The factors that are contributing to the market growth are the evidence of contamination that is present in the food products, which is supported by the human biomarker data, which indicates that most of the population is highly exposed to this illness which can cause death. There are evidences available that both animals and human beings are affected by the aflatoxin if it is not treated. The immunity and nutrition levels are affected.
Global Aflatoxicosis Treatment Market: Competitive Players
The key market players that are involved in the aflatoxicosis treatment market include Sanofi, Zydus Cadilla, Johnson and Johnson, Pfizer Inc., Abbott Laboratories, Glaxo Smith Kline, and many others.
Global Aflatoxicosis Treatment Market: Regional Segment Analysis
What Reports Provides